Perspective Therapeutics (FRA:AAJ) Tax Provision : €-7.20 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics Tax Provision?

Perspective Therapeutics's tax provision for the three months ended in Mar. 2024 was €0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2024 was €-7.20 Mil.

Perspective Therapeutics Tax Provision Historical Data

The historical data trend for Perspective Therapeutics's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Tax Provision Chart

Perspective Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Dec23

Tax Provision

Get a 7-Day Free Trial

2.43

Perspective Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Tax Provision	Get a 7-Day Free Trial															9.81	-	-	-7.20	-

Perspective Therapeutics Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.20 Mil.

Perspective Therapeutics (FRA:AAJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ:Germany

Address

350 Hills Street, Suite 106, Richland, WA, USA, 99354

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.

Perspective Therapeutics (FRA:AAJ) Headlines

No Headlines